Group 1 - The company announced that it will hold a staff representative meeting on August 8, 2025 [1] - During the meeting, the staff representatives voted to elect Ms. Shang Zhuoting and Ms. Xu Lijiao as representatives on the company's second board of directors [1]

Core Insights - The core viewpoint of the news is the performance and holdings of the Agricultural Bank of China Healthcare Stock Fund, which has shown significant growth in recent months and has a diversified portfolio in the healthcare sector [1]. Fund Performance - The latest net value of the Agricultural Bank of China Healthcare Stock Fund is 1.9772 yuan, reflecting a growth of 1.81% [1]. - The fund's return over the past month is 9.64%, ranking 129 out of 328 in its category [1]. - Over the last six months, the fund has achieved a return of 47.35%, ranking 12 out of 316 [1]. - Year-to-date, the fund has a return of 45.00%, ranking 18 out of 316 [1]. Fund Holdings - The top ten holdings of the Agricultural Bank of China Healthcare Stock Fund account for a total of 51.10% of the portfolio, with the following key positions: - Heng Rui Medicine: 8.16% - Zai Lab: 7.99% - Xin Li Tai: 5.84% - Rejig Bio: 5.63% - Kelun Pharmaceutical: 5.02% - HAO OBO: 4.36% - BeiGene: 3.61% - Yifang Bio: 3.58% - Aosaikang: 3.52% - Bid Pharma: 3.39% [1]. Fund Background - The Agricultural Bank of China Healthcare Stock Fund was established on February 10, 2015, and as of June 30, 2025, it has a total scale of 1.441 billion yuan [1]. - The fund manager is Meng Yuan, who has a master's degree and has held various positions in the fund management industry, including roles at Bank of China Fund Management and Agricultural Bank of China Asset Management [1].

证券代码：688073 证券简称：毕得医药 公告编号：2025-070 上海毕得医药科技股份有限公司 关于公司董事辞职暨选举职工董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 上海毕得医药科技股份有限公司（以下简称"公司"）董事会近日收到赵芸 女士、张锐豪先生提交的书面辞职报告。因公司内部工作调整，赵芸女士辞去公 司董事及审计委员会委员、薪酬与考核委员会委员职务，张锐豪先生辞去公司董 事及战略委员会委员职务，辞任后，赵芸女士、张锐豪先生仍然担任公司其他职 务。公司于 2025 年 8 月 8 日召开职工代表大会，经全体与会职工代表表决，同 意选举尚卓婷女士、许丽姣女士担任公司第二届董事会职工代表董事。 一、董事离任情况 根据《公司法》《上海证券交易所科创板股票上市规则》等法律法规以及《公 司章程》的相关规定，公司于 2025 年 8 月 8 日召开职工代表大会，经与会代表 认真审议并投票表决，同意选取尚卓婷女士、许丽姣女士为公司第二届董事会职 工代表董事。公司对选举结果进行了公示，2025 年 8 ...

Core Insights - The core viewpoint of the news is the performance and holdings of the Agricultural Bank of China Healthcare Stock Fund, which has shown significant growth in recent months and has a diversified portfolio in the healthcare sector [1]. Fund Performance - The latest net value of the Agricultural Bank of China Healthcare Stock Fund is 1.9462 yuan, reflecting a growth of 2.54% [1]. - The fund's return over the past month is 11.14%, ranking 101 out of 333 in its category [1]. - Over the last six months, the fund has achieved a return of 46.50%, ranking 10 out of 327 [1]. - Year-to-date, the fund has returned 42.73%, ranking 18 out of 327 [1]. Fund Holdings - The top ten holdings of the Agricultural Bank of China Healthcare Stock Fund account for a total of 51.10% of the portfolio, with the following key positions: - Heng Rui Medicine: 8.16% - Zai Lab: 7.99% - Xin Li Tai: 5.84% - Hotgen Biotech: 5.63% - Kelun Pharmaceutical: 5.02% - HAOYOBIO: 4.36% - BeiGene: 3.61% - Eucure Biopharma: 3.58% - Aosaikang: 3.52% - Bide Pharmaceutical: 3.39% [1]. Fund Background - The Agricultural Bank of China Healthcare Stock Fund was established on February 10, 2015, and as of June 30, 2025, it has a total scale of 1.441 billion yuan [1]. - The fund manager is Meng Yuan, who has a master's degree and has held various positions in the financial industry, including roles at Bank of China Fund Management and Agricultural Bank of China Asset Management [1].

金融界2025年8月7日消息，农银医疗保健股票(000913) 最新净值1.9104元，下跌2.32%。该基金近1个月 收益率13.71%，同类排名42|409；近6个月收益率44.13%，同类排名17|397；今年来收益率40.10%，同 类排名23|395。 农银医疗保健股票股票持仓前十占比合计51.10%，分别为：恒瑞医药（8.16%）、泽璟制药-U （7.99%）、信立泰（5.84%）、热景生物（5.63%）、科伦药业（5.02%）、浩欧博（4.36%）、百济神 州-U（3.61%）、益方生物-U（3.58%）、奥赛康（3.52%）、毕得医药（3.39%）。 公开资料显示，农银医疗保健股票基金成立于2015年2月10日，截至2025年6月30日，农银医疗保健股票 规模14.41亿元，基金经理为梦圆。 简历显示：梦圆女士:硕士研究生,中国。历任中银基金管理有限公司研究员、农银汇理基金管理有限公 司基金经理助理,现任农银汇理基金管理有限公司基金经理。2021年2月24日担任农银汇理医疗保健主题 股票型证券投资基金基金经理。2021年2月24日担任农银汇理创新医疗混合型证券投资基金基金经理。 来源：金融界 ...

Core Points - The Shanghai Composite Index closed at 3638.40 points with a change of 0.12% and a total trading volume of 1,206.179 billion yuan [1] - Eight A-shares experienced a crossover where the 5-day moving average fell below the 10-day moving average, indicating potential bearish trends [1] Group 1: Stock Performance - Stock "信立泰" (Code: 002294) decreased by 1.86% with a 5-day moving average of 49.37 yuan and a 10-day moving average of 49.62 yuan, showing a distance of -0.49% [1] - Stock "万邦德" (Code: 002082) decreased by 1.36% with a 5-day moving average of 7.48 yuan and a 10-day moving average of 7.52 yuan, also showing a distance of -0.49% [1] - Stock "毕得医药" (Code: 688073) decreased by 2.96% with a 5-day moving average of 59.09 yuan and a 10-day moving average of 59.27 yuan, indicating a distance of -0.30% [1] Group 2: Additional Stocks with Moving Average Crossovers - Stock "吉贝尔" (Code: 688566) decreased by 3.58% with a 5-day moving average of 33.90 yuan and a 10-day moving average of 33.97 yuan, showing a distance of -0.20% [1] - Stock "诺诚健华" (Code: 688428) decreased by 6.03% with a 5-day moving average of 30.02 yuan and a 10-day moving average of 30.07 yuan, indicating a distance of -0.18% [1] - Stock "丽人丽妆" (Code: 605136) increased by 0.81% with a 5-day moving average of 9.82 yuan and a 10-day moving average of 9.84 yuan, showing a distance of -0.15% [1]

Core Viewpoint - The A-share market is experiencing a slight decline, with the Shanghai Composite Index down by 0.28% and a total trading volume of 878.86 billion yuan as of 10:30 AM [1] Group 1: Market Performance - The Shanghai Composite Index is at 3623.70 points, reflecting a decrease of 0.28% [1] - The total trading volume in the A-share market is reported at 878.86 billion yuan [1] Group 2: Moving Averages Analysis - Seven A-shares have seen their 5-day moving averages cross below their 10-day moving averages, indicating potential bearish trends [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Xintai (002294) with a distance of -0.51% - Wanbangde (002082) with a distance of -0.45% - Haixiang Pharmaceutical (002099) with a distance of -0.24% [1] Group 3: Individual Stock Performance - Xintai (002294) is down by 2.07% with a latest price of 47.79 yuan, which is 3.66% below its 10-day moving average [1] - Wanbangde (002082) has decreased by 0.95%, trading at 7.30 yuan, 2.93% below its 10-day moving average [1] - Haixiang Pharmaceutical (002099) is down by 0.33%, with a latest price of 6.08 yuan, 1.95% below its 10-day moving average [1] - Other stocks such as Bidai Pharmaceutical (688073) and Kewah (002335) also show declines in their respective prices and moving averages [1]

Group 1 - The stock price of Bid Pharma closed at 58.79 yuan on August 6, 2025, down by 1.78 yuan, representing a decline of 2.94% from the previous trading day [1] - The opening price on the same day was 61.50 yuan, with a highest price of 61.95 yuan and a lowest price of 58.60 yuan, with a trading volume of 14,360 lots and a transaction amount of 86 million yuan [1] - Bid Pharma operates in the biopharmaceutical industry, focusing on pharmaceutical research and development services, and is recognized as a specialized and innovative enterprise in the Shanghai market, also involved in the CRO business [1] Group 2 - On August 6, the net outflow of main funds was 5.3635 million yuan, accounting for 0.21% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow reached 11.2451 million yuan, representing 0.44% of the circulating market value [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688073 证券简称：毕得医药 公告编号：2025-068 上海毕得医药科技股份有限公司 2025年第四次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次会议是否有被否决议案：无 一、会议召开和出席情况 （一）股东大会召开的时间：2025年7月31日 （二）股东大会召开的地点：上海市杨浦区翔殷路999号3幢6层会议室 （三）出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其持有表决权数量的情 况： ■ 二、议案审议情况 （一）非累积投票议案 1、议案名称：关于变更公司经营范围、取消监事会及修改《公司章程》并办理工商变更登记的议案 审议结果：通过 表决情况： （四）表决方式是否符合《公司法》及公司章程的规定，大会主持情况等。 本次股东大会由董事长戴岚女士主持，会议采用现场投票与网络投票相结合的表决方式进行表决。本次 会议的召集、召开符合《公司法》《公司章程》《公司股东大会议事规则》等法律、法规和规范性文件 ...

| 证券代码：688073 证券简称：毕得医药 公告编号：2025-068 | | | | | | | --- | --- | --- | --- | --- | --- | | 上海毕得医药科技股份有限公司 | | | | | | | 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 | | | | | | | 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 | | | | | | | 重要内容提示： | | | | | | | ? 本次会议是否有被否决议案：无 | | | | | | | 一、 会议召开和出席情况 | | | | | | | 股东大会召开的时间：2025 7 （一） 年 日 | 31 月 | | | | | | （二） 股东大会召开的地点：上海市杨浦区翔殷路 号 | | 999 | 3 幢 | 6 层会议室 | | | （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 | | | | | | | 其持有表决权数量的情况： | | | | | | | 普通股股东人数 | | | 37 | | | | 52,570,712 普通股股东所 ...